Description
 Doxorubicin HCl is an anthracycline antibiotic that inhibits cancer progression by suppressing DNA replication.  It is the 12-hydroxylated form of daunorubicin and causes DNA intercalation.  It also inhibits topoisomerase II.  Doxorubicin is researched for its efficacy against non-Hodgkin’s lymphoma, multiple myeloma, acute leukemias, Kaposi sarcoma, Wilm tumor, Ewing sarcoma, and cancers of the breast, lung, ovary, endometrium, and adrenal cortex.  Doxorubicin is an MRP-1 substrate and has been used in drug-resistance studies. 
  Product Specifications
 Doxorubicin HCl, USP Grade 
  Formula: C27H29NO11 ∙ HCl 
  MW: 579.98 g/mol 
  Storage/Handling: Store desiccated at 2-8 °C.  Protect from light. 
  PubChem Chemical ID: 443939